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1. Introduction 
In an oxidation-reduction balance, the antioxidant and oxidant molecules are in equilibrium 
in the organism. When a free radical increase causes an increase in the activity of the 
antioxidant systems, this leads to a state of redox homeostasis. The oxidation-reduction 
balance loss in the organism, caused by an excess of oxidants or a deficit in the antioxidant 
system, is defined as an oxidative-stress state, which is characterized by high levels of 
reactive species.  
The oxidative-stress state has an important role in the development of many degenerative 
diseases, such as autoimmune disease, cancer, cardiac disease, and diabetes, but it also has a 
crucial role in the neurodegenerative diseases, such as Alzheimer’s (Pan et al., 2011), 
Parkinson’s (Sevcsik et al., 2011), Huntington’s (Lee et al., 2011), lateral amyotrophic 
sclerosis (Zhao et al., 2011), multiple Sclerosis (Witherrick et al., 2010), and other processes 
related to pathological aging (Flovd et al., 2011). 
Brain plasticity allows certain mental functions to work normally, e.g the learning and 
memory process. The synapses that form between the neurons are highly organized and are 
specific structures that permit fast and highly selective interactions between the cells in 
response to the constant environmental changes that produce neuroplasticity (Bruel-
Jungerman et al., 2011). This allows the cells of the nervous system to be both functional and 
continuously structurally modified to establish new dendrites and synaptic connections. The 
brain plasticity process can be altered by oxidative stress, which produces oxidative 
damage, loss of process, synapse deaths, and alteration in the formation of new cells (Rivas-
Arancibia et al., 2010).  
The synaptic transmission involves the liberation of neurotransmitters from the presynaptic 
neurons and their detection by a specific receptor on the surface of the membrane of the 
postsynaptic neuron. Under conditions of homeostasis, the synaptic plasticity is regulated 
by changes in the amount of receptors in the postsynaptic membrane, changes in the form 
and size of the dendrite spines, and kinetic modulation of the protein synthesis and 
degradation. 
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The reactive species produce oxidation of lipids, proteins, and DNA in the cell, unfolding 
the proteins. The oxidation of the molecules that form the cell membrane alters its selective 
permeability, which leads to a loss of osmotic balance. 
Smythies (1999) proposed the redox hypothesis of learning and neurocomputing. This 
hypothesis suggests that redox signals may control a mechanism involved in brain 
plasticity, in which the growth and elimination of synapses and dendrite spines depend on 
the redox state. The fate of a synapse depending in part on the redox balance means that if 
the oxidant-environmental cell produces an oxidative-stressed state, and the reactive oxygen 
species (ROS) cause elimination of spines. This has been demonstrated in alcoholism and 
neurodegenerative diseases (Götz et al, 2001). If the cell’s environmental are antioxidant, 
synapses are preserved (Smythies, 1999) and increase the number of synapses, facilitating 
plastic brain phenomena. The central nervous system (CNS) is especially sensitive to the 
oxidants because of its high lipid content, high consumption of oxygen, and low levels of 
antioxidant enzymes. The hippocampus, substantia nigra, and the striatum are particularly 
vulnerable to oxidative stress (Rivas-Arancibia et al., 2010; Santiago-López et al., 2010). The 
vulnerability of these structures is probably caused by the neurochemical and metabolic 
characteristics of neural network. The hippocampus contains neurotransmitters such as 
acetylcholine and glutamate, and also has the ability to produce new neurons in the dentate 
gyrus, which make it susceptible to redox changes. This response is in part modulated by 
oxidative changes and an excess of reactive species block neurogenesis (Rivas-Arancibia et 
al., 2010). In the substantia nigra and the striatum, the normal metabolism of dopamine 
involves many oxidative reactions. In a state of redox balance, the dopamine oxidation does 
not disrupt normal metabolism of dopamine, because oxidized dopamine is converted by a 
complex series of reactions to neuromelanin. The loss of the redox balance causes oxidation 
of cytoplasmic dopamine in the presence of transition metals, with the formation of 
superoxide, hydrogen peroxide, and the hydroxyl radical. The dopaminergic neurons in the 
substantia nigra are involved in different functions such as learning and memory processes 
and motor control. With a loss of redox equilibrium, these neurons easily suffer oxidative 
damage and begin to produce a chain of events, in which the synthesis and metabolic path 
of dopamine contribute to the increase of the oxidative stress state because of quinone 
formation, making the nigroestriatal pathway much more vulnerable to damage in 
comparison to other brain structures (Santiago López et al., 2010). 
2. Free radicals, reactive species formation, and cell signaling 
A free radical is a species containing one or more unpaired electrons with the ability to 
exist independently (Halliwell, 2006, 2007). Free radicals are highly reactive, but despite 
their chemical reactivity, this reactivity changes over a wide spectrum. The first organic 
free radical was identified by Gomberg in 1900, the methyl triphenyl radical. More than 50 
years ago, free radicals were described in living systems in a classic work by Commoner & 
Townsed published in Nature (1954). Subsequently, it was proposed that free radicals of 
oxygen (or reactive species of oxygen), could be formed as products of the enzymatic 
reactions of cell metabolism. At that time the theory was that the reactive oxygen species 
(ROS) could be the direct cause of many diseases, including cancer and almost any 
neurodegenerative process (Harman, 1956). In the 1960s and 1970s, free radicals began to 
be considered as important elements in biological systems. Among other findings, the 
enzyme superoxide dismutase (SOD) was discovered that converts the free radical 
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superoxide ( O2-) into hydrogen peroxide (H2O2) (McCord & Fridovich, 1969). This finding 
convincingly proved the importance of the free radical in biological systems. The simplest 
of the free radicals is the hydrogen atom, with a single proton and a single unpaired 
electron. The elimination of a hydrogen atom from a biological molecule produces an 
unpaired electron on the atom or molecule to which the hydrogen atom was originally 
bonded. 
The diatomic molecule of oxygen (O2) is regarded as a radical because it has two unpaired 
electrons, each located in a different orbital, but the two have the same spin. This is why O2 
has a relatively low reactivity in contrast with other highly reactive radicals. The radicals 
can be formed by the loss of a single electron or by the gain of a single electron, each action 
from some stable molecule. A radical could donate its unpaired electron to another molecule 
or could also trap an electron from another molecule turning the latter into a free radical. 
The unpaired electrons increase the chemical reactivity of the molecule. It is the 
manifestation of the free radical to get to the most energetically stable state through pairing 
with another electron. Thus, many radical-radical and radical-molecule reactions take place 
as soon as two molecules of the reaction are found. In addition the molecules would be 
changed by this type of reaction. The high reactivity of free radicals causes their half-life to 
be brief, on the order of milliseconds, varying according to the type of free radical. 
3. How are the reactive species formed? 
In biological systems, free radicals and the intermediate products of the biological 
metabolism are formed. Both free radicals and metabolites are called reactive species. Those 
most often found are reactive oxygen species (ROS) and reactive nitrogen species (RNS). 
There are also reactive iron species (RIS) and reactive copper species (RCS) (Valko et al., 
2007).  
3.1 Reactive oxygen species (ROS) 
About 60 years ago, it was not thought that the ROS were part of the biological system 
reactions because of their high reactivity and low selectivity. More than 90% of the oxygen 
that enters into the cells is used for the production of energy. The mitochondria produce 
more than 80% of the adenosine triphosphate (ATP) necessary in animal cells. During this 
process, four electrons are added to each molecule of O2 resulting in the formation of two 
molecules of H2O. During the phosphorylation oxidative process, 1% to 5% of the O2 used 
by the mitochondria via complex I and III (Buetler et al., 2004) escape the respiratory 
chain to form the superoxide anion. Some of these molecules contain an unpaired 
electron, thus a free radical. The intermediate products have several levels of reactivity 
with non free radical species. Different ROS often coexist, and it is difficult to identify the 
specific species as responsible for a given biological effect. For example, different reactive 
oxygen species formed from the elimination of the superoxide can participate in different 
types of reactions during which cellular metabolism can suffer a oxidation or reduction 
process.  
3.1.1 Superoxide anion 
This is a relatively unreactive species but potentially toxic. It can start reactions that give rise 
to other reactive ROS. This new anion can be formed as a product of many reactions 
catalyzed enzymatically, as in flavoprotein reactions (Xanthine oxidase, aldehyde oxidase, 
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purine oxidase) (Behar et al., 1979; Korycka-Dahi & Richardson, 1981), oxidases and 
hydroxylases (diamino oxidase, galactose oxidase, cytochrome p450), and also those that can 
be formed in nonenzymatic reactions of oxygen with cysteine (Sáez et al., 1982) or riboflavin, 
as happens in the mitochondrial respiratory chain (Boveris, 1972). 
 
 
Fig. 1. Schematic oxidation-reduction reactions. Note the reduction reactions in a redox 
balance (left), and oxidation reactions in an oxidative stress condition (right) 
 
 
Reaction 1. Formation of Superoxide anion 
3.1.2 Hydrogen peroxide (H2O2) 
Hydrogen peroxide is not a free radical, but it is a reactive oxygen species that can easily 
diffuse through the membranes. In biological media it is formed by two pathways; 1) After 
the direct reduction of the oxygen by two electrons (reaction 2) and 2) By the catalyzation of 
the superoxide anion with SOD (reaction 3). 
Many enzymes produce hydrogen peroxide from oxygen, such as xanthine oxide reductase, 
superoxide dismutase, glucose oxidase, D-amino acid oxidase, uricase (Battaner et al., 1990; 
Fridovich, 1986; Janolino & Swaisgood, 1975; Romero-Alvira et al., 1987) and may also result 
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from chemical reactions such as the autoxidation of ascorbic acid catalyzed by copper 
(Korycka-Dahi & Richardson, 1991). 
 
 
Reaction 2. Reduction of oxygen 
 
 
Reaction 3. Dismutation of superoxide anion 
3.1.3 Hydroxyl (•OH) 
This is the most reactive species, with an average life estimated of about 10-9 seconds 
(Liochev & Fridovich, 1994). Because of Its high reactivity its chemical action is confined to 
the vicinity of the site of production. It can be formed in vivo as a result of high-energy 
radiation (x-ray, gamma ray), which can cause homolytic breakage of water. UV light does 
not have enough energy to split a water molecule but it can split oxygenated water into two 
molecules of the hydroxyl radical. At the biological level, the most important hydroxyl 
radical formation is the Fenton reaction (Halliwel & Guteridge, 1992) (reaction 4). 
 
 
Reaction 4. Hydroxyl radical formation. Fenton reaction 
Hydrogen peroxide and the superoxide radical can form the hydroxyl radical by the Haber-
Weiss reaction (Wardman, 1996) (Reaction 5): 
 
 
Reaction 5. Hydroxyl radical formation, the Haber-Weiss reaction. This reaction is catalyzed 
by metals such as iron or copper 
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3.1.4 Peroxyl radical (ROO•) 
The peroxyl radicals are probably the most abundant in biological systems, and they are not 
as reactive as the ROS. They originate from the addition of oxygen to any hydrocarbon 
radical (reaction 6). This radical has a relatively long half-life (on the order of seconds). 
 
 
Reaction 6. Production of the peroxyl radical 
3.1.5 Oxygen singlet (1O2) 
This is an excited form of molecular oxygen. It is not a free radical and it is formed in vivo 
by the action of light on oxygen molecules in the presence of photoactivators, such as 
riboflavin (Aurand et al., 1977). Its half-life is about 10-6 seconds, depending on the nature of 
the surrounding matrix. It can interact with other molecules by transferring to them its 
excitation energy or by chemically combining with them. It can form in the oxidation of 
NADPH in the microsomes by the activity of several enzymes such as xanthine oxidase, 
lactoperoxidase, lipoxygenase, and prostaglandin synthetase. 
3.1.6 Nitric oxide (•NO) 
It is a lyophilic and water-soluble gas, with an average half-life of 3 to 5 seconds. 
Enzymatically formed from arginine, its reaction is catalyzed by nitric oxide synthase 
(NOS). The NOS has three isoforms. The neuronal nitric oxide synthase (nNOS) or type I, 
the inducible nitric oxide synthase (iNOS) or type II, and the endothelial nitric oxide 
synthase (eNOS) or type III. They are constitutively expressed. Their activity is regulated 
by the intracellular concentration of calcium (Bredt et al., 1991). The inducible nitric oxide 
synthase (iNOS) or type II is expressed in the macrophages when they are stimulated by 
cytokines, lipopolysaccharides, or other immune substances. It is also is found in other 
tissues, such as brain tissue and endothelium (MacMicking et al., 1997). Its expression is 
regulated at both the transcriptional and posttranscriptional level, which involves the 
transcription by redox signaling as an increase in reactive species and cytokines, such as 
nuclear factor kappa B (NF-kB) and the MAP kinases (MacMicking et al., 1997). Nitric 
oxide plays a fundamental role in the regulation of local blood flow, inhibits platelet 
aggregation, is a neurotransmitter, and is produced by activated macrophages that 
contribute to the primary immune defense. Another effect of the NO radical is its ability 
to react with the iron of intracellular protein, mainly mitochondrial. Most of the enzymes 
that possess a heme prosthetic group can be inactivated by nitric oxide. Nitric oxide can 
react with nucleic acids leading to mutations and DNA breakage and it can also cause 
necrosis (Tang et al., 2011). 
The NO radical has an important antiinflammatory action, and it has the ability to cause 
cellular and tissue dysfunction by a proinflammatory effect. To understand this double 
effect it has been proposed that the regulatory and antiinflammatory effects of nitric oxide 
occur when it has a direct impact on a biological molecule (Grisham et al., 1999), which 
occurs under physiological conditions in which the production of NO is low and a redox 
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balance is present. However, upon the loss of the redox balance when the concentration of 
NO increases, the NO has indirect effects through metabolites associated with RNS, and 
they may react with oxygen or the superoxide radical, which occurs during oxidative stress 
and an inflammatory response (Tweedie et al., 2011). 
3.1.7 Peroxynitrite (•ONOO-) 
Nitric oxide can generate the peroxynitrite anion (ONOO-) by reaction with the superoxide 
anion (Gryglewsli et al., 1986; Miles et al., 1996).  
 
 
Reaction 7. Formation of peroxynitrite anion 
4. Free radical production 
There are many ways by which organisms are exposed to the effects of oxygen free radicals. 
Free radicals can be produced through several chemical processes, both within and outside 
the organism. The same cell is potentially more than one source of production of a free 
radical. Depending on the origin of its production, the peroxynitrite can be in equilibrium 
with its conjugate acid (ONOOH). In neutral solution it is a powerful oxidizing agent able to 
nitrate tyrosine residues, nitrating and oxidizing guanosine, degrade carbohydrates, initiate 
lipid peroxidation, and fragment DNA (Beckman & Koppenol, 1994, 1996). 
The production of O2- and NO in vivo is different. The peroxynitrite production always 
occurs when there is an excess of one or the other (Grisham et al., 1999). Some authors 
established that both reactions of oxidation and nitration mediated by the peroxynitrite are 
influenced largely by the relative flow of production of O2- and NO (Jourd’Heuil et al., 
2001). They also established that the highest rates of oxidation occur with an excess of NO, 
producing oxidation through the OH and from the peroxynitrite NO2 formed. However, 
the reaction of peroxynitrite with CO2 is the most important way that the peroxynitrite 
decomposes in vivo (Lymar & Hurst, 1995), forming the end product N2O3, which is a 
potent nitrating agent.  
In addition to the reactions of oxidation, the peroxynitrite has the ability to nitrate phenolic 
compounds under physiological conditions, such as the rings of tyrosine (Goldstein et al., 
2000). Tyrosine residues are oxidized by the radical derivatives of the peroxynitrite forming 
the radical tyrosyl, which in turn reacts with NO to form 3-nitrotyrosine. The nitration 
mediated by peroxynitrite in vivo might be inhibited by a relative overproduction of O2- 
because of competition between them by the radical tyrosyl, by which the formation of 3-
nitrotyrosine would be inhibited when the rate of formation of O2- exceeded that of NO 
(Goldstein et al., 2000) in the exogenous and endogenous sources (Freeman & Crapo, 1982). 
4.1 Exogenous ROS production 
Many antineoplastic agents (Dedon & Goldberg, 1982), such as the adriamycin, bleomycin, 
daunorubicin, and other antibiotics (Doroshow & Hochstein, 1982) depend on quinoide 
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groups or joining metals for their activity. Some of the effects of these drugs have been 
attributed to their ability to reduce oxygen to superoxide, the hydroxyl radical, and 
hydrogen peroxide. The irradiation of organisms by electromagnetic radiation (x-rays and 
gamma rays) or by particle radiation (electrons, protons, deuterons, and neutrons) also 
cause free radicals (Bielsky & Gebieki, 1977). 
Environmental factors, such as photochemical air pollutants as ozone, hyperoxia, pesticides, 
tobacco smoke, solvents, anesthetics, and aromatic hydrocarbons are a source of reactive 
species. These agents have free radicals, such as in tobacco smoke, or become reactive 
species with cellular metabolism and detoxification processes (Mason, 1982). An important 
source of reactive species that deserves special importance is environmental pollution 
(Searing & Rabinovitch, 2011; Bhalla, 1999) because it has been shown that an oxidation 
environment, in which we live in polluted cities, is associated with chronic-degenerative 
diseases. An example is ozone pollution (Bhalla & Gupta, 2000). Studies have shown that 
ozone pollution causes serious damage to human health and is a determining factor in the 
progression of neurodegenerative diseases (Zawia et al., 2009; Schwela, 2000). This gas acts 
to produce ROS in the body, causing an increase in oxidants, increasing the state of 
oxidative stress in the organism and thus contributing to increase the neurodegenerative 
process in the patient (Cretu et al., 2010).  
4.2 Endogenous ROS production 
Autoxidation of small molecules. There are a variety of soluble components able to produce 
phosphorylation in the cell, such as thiols, hydroquinone, catecholamines, flavins, and 
tetrahydropterins. In all these, the superoxide radical is the radical primarily formed by the 
dioxygen reduction by these molecules (Baccarini, 1978). Hydrogen peroxide is also 
produced as a byproduct from the disproportionation of the superoxide radical, either 
spontaneously or enzymatically catalyzed by superoxide dismutase (SOD). 
4.2.1 Soluble enzymes and proteins 
 Enzymes, such as xanthine oxide reductase, aldehyde oxidase, flavinprotein 
dehydrogenase, and tryptophan dioxygenase, generate free radicals during their catalytic 
cycle (Massey et al., 1989). During ischemia, calcium stimulates the activation of proteases 
leading to changes in the activation of these enzymes (Warner et al., 2004) causing cell 
damage and death.  
4.2.2 Mitochondrial electronic transport chain 
In healthy tissue, one of the main sources of free radicals are the mitochondria. This is 
because these organelles are responsible for more than 90% of cellular oxygen consumption 
and the radicals in biological systems always, ultimately are generated by the metabolism of 
oxygen by this route. 
Most mitochondrial hydrogen peroxide comes from the disproportionation of the 
superoxide radical (Boveris & Chance, 1973). The generation of the superoxide radical by 
mitochondria occurs when the conveyors of the respiratory chain, located in the inner 
mitochondrial membrane, are highly reduced (Turrens & Boveri, 1980). 
Four complexes are responsible for electronic transport in the respiratory chain. The 
production of radicals has been observed in the mitochondria isolated in complex I 
(Turrens & Boveri, 1980) and in complex III (Boveris & Chance, 1973). For complex I, the 
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most likely candidates as free radical generators seem to be iron-sulfide centers, whereas 
complex III has been discussed intensively to determine if they could be a semiquinone 
(Boveris & Chance, 1973) or cytochrome b (Nohl & Jordan, 1986; Turrens, 2003; Ghouleh et 
al., 2011). 
4.2.3 Electronic transport of the endoplasmic reticulum and nuclear membrane 
systems 
Both systems of intracellular membranes contain cytochromes P450 and b5, which can 
oxidize unsaturated fatty acids (Capdevila et al., 1981; Ghouleh et al., 2011) and xenobiotics 
(Chignell, 1979). The cytochromes P450 and b5 are the most powerful oxidizers in vivo, 
although they can also act as reducing agents. There are several actions that activate 
molecular oxygen species (Ghouleh et al., 2011) generating oxygen electrophílics in turn by 
radicals that can be released into the cell (Dolphin, 1988). 
4.2.4 Peroxisomes 
Peroxisomes are cellular sources of the production of hydrogen peroxide because of their 
high concentration in oxidases, none of which uses superoxide as a precursor. These 
enzymes include the D-aminoacid oxidase, urate oxidase, L-a-hydroxyacidic oxidase, and 
acyl-fatty-Coenzyme A oxidase (Boveris et al., 1973). 
Peroxisomal catalase is the enzyme that metabolizes most of the hydrogen peroxide 
generated by the peroxisomes oxidases (Freeman & Crapo, 1982; Frei, 1994). 
4.2.5 Plasma membrane 
Free radicals generated extracellularly must cross the plasma membrane before reacting 
with other cellular components and can then start toxic reactions. Unsaturated fatty acids 
present in the membrane and transmembrane proteins with oxidizable amino acids are 
likely to be altered by free radicals. These reactions affect the properties of the membranes 
by changing their permeability and decreasing the potential of the membranes, making 
secretory functions stop, and inhibiting metabolic processes in the cells. All this is caused by 
lipid peroxidation or the oxidation of important structural proteins (Freeman & Crapo, 
1982). 
5. Antioxidant systems and loss of redox balance 
In the presence of the oxygen, organisms have been forced to develop mechanisms for their 
protection against the ROS. Antioxidants are biological substances that are able to compete 
for oxidizable substrates and inhibit oxidation (Halliwell & Gutteridge, 1984). Antioxidant 
systems can be divided into enzymatic and nonenzymatic (Somogyi et al., 2007). The first 
are the SOD, glutathione peroxidase, catalase, and thioredoxin. Nonenzymatic types include 
vitamins, proteins, and amino acids, which are less reactive but in greater concentration in 
contrast to the enzymatic types, which have a high reactivity with the ROS, but are in lower 
concentrations. 
Antioxidant systems counteract the activity of the ROS, thus maintaining the oxidation-
reduction balance. These systems can be endogenous and exogenous. The most important 
endogenous antioxidant systems are the enzymes superoxide dismutase, catalase, and 
glutathione peroxidase.  
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Fig. 2. Shows an oxygen free radical (1), which in the presence of the enzyme Cu-Zn SOD (2) 
gives rise to peroxides (3) that react with reduced glutathione (4) and are catalyzed by the 
enzyme glutathione peroxidase (5) resulting in oxidized glutathione (6) and water (7). The 
peroxides (3) that can be toxic to the cell are removed. The oxidized glutathione (6) in the 
presence of glutathione reductase (8) and NADPH (9), which hosts an electron, allows the 
oxidized glutathione to return to its reduced form 
5.1 Endogenous systems 
5.1.1 Superoxide dismutase (SOD) 
The catalytic role of the SOD was discovered by McCord and Fridovich in 1969. The SOD is 
an enzyme that catalyzes the reduction of the superoxide anion, which is produced in the 
body as the resulting product of oxidative phosphorylation, either derived from UV 
radiation or during inflammation, by transforming the superoxide anion into a product such 
as hydrogen peroxide that is metabolized easily to water by glutathione peroxidase (GPx) 
and catalase (CAT).The SOD is present in different forms, such as copper-zinc SOD and 
manganese SOD (Mn-SOD). The Cu-Zn SOD is found in the cytosol and the cell membrane, 
has a molecular mass of 32 kDa with two identical subunits. The Mn-SOD is located in the 
mitochondrial matrix (Grisham et al., 1999; Halliwell & Gutteridge, 1989; Ohno et al., 1994) 
and has a molecular mass of 88 kDa with four identical subunits (Ohno et al., 1994). It acts as 
a first line of defense in the detoxification of the superoxide anion and seems to be involved 
in processes of tumor removal or cellular differentiation. 
5.1.2 The glutathione antioxidant system 
The glutathione antioxidant system is formed by reduced glutathione and the activity of the 
enzyme glutathione reductase that reduces the oxidized glutathione and glutathione 
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peroxidase, which along with the reduced glutathione contributes to the elimination of 
peroxides. Glutathione (GSH) is a tripeptide compound of glutamic acid, cysteine, and 
glycine that has many important functions within cells (Fig. 3). Glutathione serves as a 
reducer, conjugates to drugs to make them more soluble in water, is involved in the 
transport of amino acids across cell membranes (Ǆ-glutamyl cycle), is a substrate for the 
peptide-leukotrienes, serves as a cofactor for some enzyme reactions, and as an aid in the 
reorganization of protein bridges. 
 
 
Fig. 3. Structure of glutathione 
The role of GSH as a reducing agent is important especially in a highly oxidizing environment. 
The sulfhydryl of GSH can be used to reduce peroxides. The resulting form of oxidized GSH 
consists of two molecules of disulfide linked together (GSSG). Glutathione reductase uses 
NADPH as the cofactor to reduce GSSG to two molecules of GSH. Therefore, the pentose 
phosphate pathway is important to produce the NADPH required for glutathione reductase. 
Glutathione peroxidase is a selenium-dependent enzyme that catalyzes the reduction of 
H2O2 or lipoperoxide (L-OOH) using the reduced glutathione (GSH). 
Oxidized glutathione is reduced by glutathione reductase that uses NADPH (from the 
pentose phosphate pathway) as an electron donor, thus maintaining the ratio GSH /GSSG 
(Fig. 4). There are at least three forms of glutathione peroxidase dependent on selenium; an 
intracellular form, extracellular (GPx-C), or plasma (GPx-P) that has specific activity for 
phospho-lipoperoxides (GPx-PH), usually associated with the membrane and although its 
activity is the same, has structural differences. The GPx-C and GPx-P are tetrameric 
enzymes composed of four identical subunits with each containing a selenium atom 
attached covalently to a molecule of cysteine. The sequence of amino acids in the subunits of 
the GPx-C is different from the sequence of the GPx-P. The separate subunits have no 
catalytic activity. The GPx-PH is a monomer enzyme that also has an atom of selenium and 
catalytic activity (Stepanik & Ewing, 1993). The GPx-C has higher affinity for H2O2 than for 
lipoperoxides, and the GPx-P has a similar affinity for the two substrates. The GPx-C and 
GPx-P are used as substrates for H2O2 and the lipoperoxides. They are not able to use the 
phospholipoperoxides (PHL-OOH) that are the major substrates for the GPx-PH (Maiorino 
et al., 1991). 
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(a) 
 
 
(b) 
Fig. 4. (a) Reduced glutathione structure (GSH). (b) Oxidized glutathione structure (GSSG) 
5.1.3 Catalase 
Catalase (CAT) or hydrogen peroxide oxidoreductase is one of the more abundant enzymes 
in nature and is widely distributed in the human body. Its activity varies depending on the 
tissue, highest in the liver and kidneys, lowest in connective tissue and the lining, and 
practically nonexistent in the nervous tissue. At the cellular level it is located in the 
mitochondria and peroxisomes, except in erythrocytes, where it is located in the cytosol. 
This enzyme is a tetrameric metaloprotein of four identical subunits that are held together 
by noncovalent interactions. Each subunit contains a prosthetic group of protoporphyrin IX. 
Catalase is involved in the destruction of hydrogen peroxide generated during cellular 
metabolism. It has two features; the catalytic and the peroxidative. Both can be represented 
by reaction 9. 
The general reaction covers the substrate reduction taking hydrogen atoms from a donor, 
and the products are the reduced substrate and the oxidized donor. In the catalytic reaction, 
the donor is another molecule of H2O2. This reaction can only be accomplished by the 
enzyme in its tetrameric form. 
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Reaction 9. Destruction of hydrogen peroxide by catalase 
 
 
Reaction 10. Catalytic reaction of the enzyme catalase on hydrogen peroxide 
In the peroxidative reaction the enzyme can be used as donors of hydrogen to methanol, 
ethanol, formic acid, and formaldehyde. This reaction can be with monomers, dimers, and 
tetramers. Glutathione peroxidase (GPx) and glutathione reductase (GRd) are part of an 
antioxidant system (GPx-GRd), and catalase (SOD-CAT). It has been observed that both 
systems fail to act simultaneously. The CAT acts in the presence of high concentrations of 
H2O2, and the GPx at low concentrations, which shows an inverse correlation in the activity 
of two enzymes. 
5.2 Exogenous systems 
Antioxidant vitamins, along with glutathione, comprise a group of reducing agents able to 
donate electrons to oxidized species such as free radicals and the lipoperoxides, thus 
neutralizing their destructive oxidative potential (Chao et al., 2002).The most significant 
exogenous antioxidant systems are vitamins A, C, and E, and some metals such as copper 
and selenium. The last is a cofactor for the enzyme glutathione peroxidase. 
Vitamin A. It can be derived from retinol of animal origin and comes from different plant 
carotenes. The main sources of vitamin A are fish liver oils, liver of mammals, and milk. In 
plants it exists in the form of carotene (provitamin). It has an important role in vision. In the 
form of retinoic acid, vitamin A is effective in the treatment of acne and other skin 
conditions.  
Vitamin E is a substituted lipid isoprenoid of the tocopherol family. Its biologically active 
form is D-alpha tocopherol, whose phenolic hydroxyl is responsible for the antioxidant 
effects. Vitamin B12 is plentiful in the yolk of eggs, whole milk, the offal of mammals, and 
fish oils. It is essential for humans (Mayes, 1997). The activity of vitamin E is one of the first 
barriers against the peroxidation of the polyunsaturated fatty acids. Mitochondrial, 
endoplasmic reticulum, and plasma membrane phospholipids have affinities to alpha-
tocopherol, so it is highly concentrated in these sites (Nenzil et al., 2001). Tocopherols act by 
interrupting free radical chain reactions because of their ability to transfer a phenolic 
hydrogen to a peroxide free radical. Vitamin E can be in the form of phenoxy or phenoxyl 
free radical, in unreversible intermediate reactions that presuppose the transformation of the 
vitamin to its final harmless products. Tocopherols and selenium act synergistically 
www.intechopen.com
 Neurodegenerative Diseases – Processes, Prevention, Protection and Monitoring 
 
66 
allowing the organism to have its antioxidant activity (Hoenyet et al., 2005). Selenium is 
required for the normal pancreatic function (Rayman, 2000), which is necessary for the 
proper digestion of lipids. Though it is known that the levels of vitamin E are correlated 
with the ability to digest and absorb lipids. Because of its hydrophobic nature a deficiency of 
tocopherols is found in processes such as hepatic cholestasis and cystic fibrosis or bowel 
resections. Recent work shows the close relationship of the increase in the requirement of 
vitamin E and selenium with the intake of unsaturated fatty acids, aging, and the 
degenerative diseases such as atherosclerosis (Penn et al., 2003), Alzheimer's disease 
(Butterfield et al., 2002), or prostatic carcinoma (Thomas, 2004). 
Vitamin C or L-ascorbic acid is a derivative of glucose. It is essential in the human diet. It is 
a lactone, in which the hydroxyl associated with the double bond groups function as agents 
with a high reducing potential, allowing it to participate in the direct reduction of oxygen, 
thus functioning as a donor substrate in the reactions of the peroxidases (Mayes, 1997). The 
mechanism of action of this vitamin yields a higher antioxidant level because it includes the 
inhibition of the formation of the superoxide radical or nitrosamines during digestion. In 
addition, it is the agent that reduces the phenoxy radical formed during vitamin E activity 
(Chao et al., 2002). Vitamins C and E are classified as antioxidant switches because they act 
by stopping the formation of free radical chain reactions (Shite et al., 2001), trapping them 
and reducing them, unlike the preventive antioxidants (which include peroxidase enzymes) 
to prevent the initiation of the sequence of reactions. Tocopherols work in an environment 
of high oxygen partial pressure, whereas beta-carotene works at low O2 partial pressures. 
 
 
Fig. 5. Action of tocopherol on lipid peroxides and regeneration in the presence of ascorbate 
and reduced glutathione 
6. Role of the reactive species in cellular signaling 
The mechanisms of oxidation-reduction and free radicals play an important role in cell 
physiology (Kovacik & Wells, 2006), from the renewal of membranes, cellular plastic 
phenomena, cell migration, synthesis and release of some hormones, increase in transcription 
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of cytokines during inflammatory processes, the participation in cell signaling (Stone & 
Yang, 2006; Biniert et al., 2006), and the mechanisms of second messengers (Smythies, 1999; 
Chiarugi & Fiaschi, 2007). 
The ROS are characterized by their dual nature, which depends on the redox state of the 
organism. In a balanced oxidation-reduction reaction, the main effects of the ROS in the cell 
are through their actions in signaling pathways. These oxidant signals can easily be offset 
through antioxidant systems, To restablish a redox equilibrium, the ROS causes the 
expression of antioxidant enzymes and related defense mechanisms. At low concentrations 
the ROS are involved in many physiological functions. It has been suggested that the main 
effects of the ROS in cells are through interactions they have with different signaling 
pathways and not by their direct action on macromolecules (Maher, 2000). Both phenomena 
do coexist. There is evidence that living organisms have not only adapted to coexist with 
free radicals but they also have generated several mechanisms for using free radicals in 
different physiological functions (Halliwell & Gutterdge, 2007; Kirkwood, 2005).  
Infectious diseases possibly were a mechanism of natural selection in the early stages of 
human civilization. The ROS participate directly in the defense mechanism against 
infections. They are part of a respiratory burst and are important modulators of the 
inflammatory response. Resident glia in the brain in normal situations are produced by ROS 
and its role in the brain is to counter cell damage. In addition, they participate in other 
functions, such as the regulation of vascular tone, the monitoring of the oxygen pressure, 
and the expansion of signal transduction. Signal transduction mediated by reactive species 
regulates the response to oxidative stress, which keeps the redox balance within homeostatic 
limits (Droge, 2002). For all this, the homeostatic regulation of the oxidation-reduction 
balance has a special importance of keeping the delicate balance between the adaptive 
advantages of the biological use of free radicals and their harmful effects. One of the most 
important discoveries is that the ROS can regulate gene expression of several bacterial 
genes, which is generated by H2O2 (Christman et al., 1985). For mammals, small amounts of 
O2- and H2O2 increase the production of interleukin 2 (IL-2), which is an important factor 
of lymphocyte growth, possibly as a response to the activation of the nuclear factor kappa B 
(NFκB) that occurs in the presence of the ROS (Schreck et al., 1992). 
The term "redox signaling" is used to describe a process of regulation, that involves 
processes of oxidation-reduction. This type of signaling is used by a wide range of 
microorganisms, including bacteria, and its most common use by the cell is the generation of 
antioxidant defenses to restore the original state of redox homeostasis after a temporary 
exposure to the ROS (Droge, 2002). The interaction of various components of antioxidant 
systems (Mendiratta et al., 1998a, 1998b) is effective for the recycling of components and is 
sufficient to cope with the stress caused by the ROS for long periods in the life of an 
organism (Soberman, 2003). Aging and particularly inflammatory, chronic diseases cause an 
alteration in the maintenance of redox state, which causes mechanisms of progressively 
aggravated pathology. 
As mentioned, the ROS generate cellular events, such as the activation of the pathway of the 
MAP. These consist of four subfamilies sensitive to the ROS and are identified as kinases 
regulated by extracellular signaling (ERK1-2), kinase c-Jun NH2 - terminal (JNK), and kinase 
p38 kinase big MAP type 1 (BMK1 or ERK5). Each family has its trigger mechanism and 
then modulates specific cellular functions (Suzaki et al., 2002). We will discuss the 
physiological role of the ROS and the path of the BMK1 or ERK5 kinase in neuronal cells. 
There is evidence, found in experiments in PC12 cells, of different intracellular signaling 
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steps identified in the path of the MAP kinases, where the ROS are involved (Suzaki et al., 
2002). 
The activation of the pathway of the BKM1 stimulated by the ROS depends on the presence 
of c-Src, a protein kinase encoded by the gene Src, and that becomes involved in the 
internalization of the signals to the nucleus through the phosphorylation of other proteins, 
including second messengers. When the ROS present in the cells interact with the c-Src, this 
causes activation of the kinase, which in turn has an immediate effect on the activation of 
the BMK1 through key intermediates to continue the internalization of the signal initiated 
by the ROS. Below is shown the cascade of the MEKK3 and MEK5 kinases (Suzaki et al., 
2002). The BMK1-ERK5 possesses a amino acid motif TEY of physiological importance 
because it is on this site where atoms join with the phosphorous kinase MEK5 (Lee et al., 
1995; Zhou et al., 1995). This, when phosphorylated, acquires the ability to cause the 
activation of the MEF2C and MEF2A, both belonging to the family of MEF2 transcription 
factors, and to cause the translocation at the nucleus, which is involved in the expression of 
genes of c-Jun and c-Fos, themselves part of the family of the AP1 (Silva, 2001). Components 
of this family have a common binding site on the DNA that results in the expression of 
neuropeptides and neurotrophins, synthesis and expression of receptors to various ligands, 
activation of transcription factors, the synthesis of various enzymes involved in the 
production of neurotransmitters, such as thyroxine hydroxylase, a limiting enzyme in the 
production of catecholamines and the formation and polymerization of proteins to the 
cytoskeleton (Silva, 2001). In endothelial cells, oxidative stress is involved in the formation  
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Fig. 6. Shows the action of reactive species on cellular signaling. In this example we can 
observ the effects of ROS on the AP1 family mediated by the pathway of MEKK3  
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of BMK1 (Yan, 1999) and this is able to phosphorylate Bad, a protein involved in the 
signaling of apoptosis. The scaffold 14-3-3 protein binds to Bad when it is phosphorylated 
and stops it from having proapoptotic activity. The nonphosphorylated Bad is able to travel 
to the mitochondria, causing the release of cytochrome C, a crucial step for the activation of 
caspase 3 (Xinchun et al., 2004). This evidence can suggest that the protective role and 
antiapoptotic action of BMK1-ERK5 is generated by the ROS (Liu et al., 2003). 
7. Inflammation response and oxidative stress 
The inflammatory response is a natural and important process in the repair of tissues and a 
fundamental mechanism of defense of the organism against infections and harmful agents. 
When the inflammatory response is not limited a process of chronic inflammation is 
established. In the animal model of oxidative stress, caused by exposure to ozone on healthy 
animals, chronic oxidative stress is able to cause an inflammatory response and 
dysregulation of the same answer (Rivas-Arancibia et al., 2010). It is widely reported that 
chronic inflammation produces ROS that lead to a state of oxidative stress. This change in 
the redox balance, causing activation of the signaling pathways of the cell, causes a 
perpetually inflammatory state. Maintaining the redox balance is important for cell 
signaling and adequate transcriptional activity (Chung et al., 2009). The ROS and other 
reactive species regulate the expression of proinflammatory cytokines, such as TNFα, IL-1ǃ, 
IL-6, and IL-8, and the cell-adhesion molecules, such as the adhesion intercellular-1 (ICAM-
1) and E-selectin molecules. Several biological states cause an increase in the amount of 
proinflammatory cytokines. Aging causes an increase in the levels of cytokines such as  
TNF-α, IL-1ǃ, IL-6, gamma interferon (IFNǄ), the beta-transforming growth factor (TGFǃ), 
and acute phase proteins (Bruunsgaard et al., 2003). High levels of IL-6 have been associated 
with neuronal atrophy and chronic inflammatory states such as diabetes type 2 and 
atherosclerosis (Devaux et al., 1997; Willette et al., 2010). The C-reactive protein (CRP) levels 
increase with ageing, and high levels of chronic diseases are found associated with ageing, 
heart disease, and Alzheimer's disease (Ridker et al., 2001). 
Activation of transcription factors that are sensitive to redox signals generate the production 
of inflammatory mediators, such as interleukin-1ǃ (IL-1ǃ), Interleukin-6 (IL-6), necrosis 
tumor-α factor (TNF-α), cycle-oxygenase-2 (COX-2), lipoxygenase (LOX), and inducible 
nitric oxide synthase (iNOS), and the cell adhesion molecules(CAMs) (VCAM-1, ICAM-1, 
and P- and E-selectin) (Salminen & Kaarniranta, 2010). NF-κB is a transcription factor 
activated by a wide variety of stimuli, such as oxidative stress, infection, and inflammation. 
This activation plays a key role in regulating the immune response (Salminen & Kaarniranta, 
2010). NF-κB is composed of a heterodimericprotein complex containing a DNA-binding 
domain and a domain of acidic transactivation formed by the heterodimer polypeptides 
RelA-p65 and p50. Normally NF-κB is linked to a protein of the IκB family in cytoplasm, 
which inhibits its activation (Baldwin, 1996). When IκB is degraded, the NF-κB is freed  
and causes its translocation to the nucleus, where the NF-κB can bind to a promoter and 
start the transcription of specific genes that encode for proinflammatory mediators. 
Activation of tNF-kB is usually transient, but chronic activation produces changes in the 
inflammatory response. Protein-generated NF-kB and COX-2, TNF-α,e, and IL-1ǃ and IL-6 
are also potent activators of the same pathway, creating a vicious cycle (Handel et al., 1995, 
Fisher et al., 1996 ). There is evidence showing that aging increases the degradation of  
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NF-kB because of phosphorylation of IKB by NIK-IKK and MAPKs (Kim et al., 2000). There 
are other transcription factors involved in the inflammatory response. The family of the 
forkhead box O (FOXO) is evolutionarily conserved and integrated by FOXO1, FOXO3a, 
FOXO4, and FOXO6 in mammals (Van der Heide et al., 2004). The FOXO activation causes 
the transcription of genes involved in the regulation of the cell-cycle metabolism, cell death, 
and resistance to oxidative stress (Hedrick, 2009). The activation of these factors of 
transcription is regulated by growth factors through the phosphorylation of protein kinase B 
(PKB) (also known as Akt). This formation of phosphoinositide 3-kinase (PI3K) leads to the 
translocation of FOXO in the cytoplasm to the nucleus (Salih & Brunet, 2008). Both protein-
kinase PI3K and Akt are able to mediate many signals of cell survival through inhibition of 
apoptosis processes (Lawlor and Alessi, 2001). However, little is known about how PI3K-
Akt regulates levels of the ROS in cells. FOXO1 reduces the degree of oxidative stress 
increasing the amount of mRNA coding for Mn-SOD and catalase (Burgering & Medema, 
2003). FOXO3a and FOXO4 protect quiescent cells in vitro from oxidative stress. FOXO3a 
directly activates the transcription of antioxidant enzymes Mn-SOD, catalase, and 
peroxiredoxin 3 (Prx3) (Marinkovic et al., 2007). This suggests that FOXO also has an 
important role in the redox balance. Both PI3K and Akt protein kinase are able to mediate 
many signals of cell survival through inhibition of apoptosis processes (Lawlor & Alessi, 
2001). 
The hypothesis of molecular inflammation can facilitate a better understanding of the aging 
process and related diseases such as dementia, cancer, osteoporosis, gingivitis, and vascular 
diseases.  
8. Loss of the redox balance 
The free radicals interact with other cell components, such as proteins, DNA, and lipids, to 
form multiple catabolic products. An example of these is lipid peroxidation resulting in lipid 
hydroperoxides and aldehydes that interact with the sulfhydryl groups of proteins causing 
the loss of protein functionality and thus perpetuating cell damage. The increased levels of 
calcium and nitric oxide stimulates the production of inflammatory interleukins causing 
gliosis and increasing the state of oxidative stress. This causes damage and cell death 
(Sugaya et al., 1998; Ryter et al., 2007), thus establishing a cycle through a chain of oxidative 
reactions that involve both neurons and glia. These are involved in the maintenance of the 
damage that extends into adjacent tissue cells. 
8.1 The role of mitochondria in oxidative stress 
Mitochondria play a critical role in maintaining cellular homeostasis. This organelle is an 
important cellular source of energy in producing ATP. In addition they maintain the 
intracellular levels of calcium within appropriate ranges to mediate cell signaling and 
control neuronal excitability and synaptic function. In the brain there is a metabolic coupling 
between vascular substrates, providing oxygen and glucose and the metabolic needs of the 
brain tissue, formed by neurons and glia alike (Foster et al., 2006).The sequence of events 
that occurs after neural stimulation includes an initial decrease of oxygen in areas of high 
demand for this gas (for example, those first stimulated) and a large further increase of 
oxygen associated with a wide field of arterial vasodilatation. These events are closely 
related to mitochondrial activity through the production of H2O2 as a signaling molecule 
(Foster et al., 2006). 
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Like other cells, nerve cells use ATP as a source of energy for biochemical processes involved 
in various cell functions, and produce ROS as a result of oxidative phosphorylation. The 
electrical excitability and structural changes, coupled with the synaptic complexity of 
neurons yields unusual demands in cellular systems that produce or respond to ATP and 
ROS. Mitochondria in axons and presynaptic terminals provide for sources of ATP to pump 
ions that are concentrated in these structures to quickly restore the subsequent ion gradients 
for depolarization and neurotransmitter release. Mitochondria also play a role in the 
regulation of synaptic functions because of their ability to regulate calcium levels and the 
production of ROS (Mattson & Liu, 2002). 
Neurons in the brain are highly vulnerable to metabolic changes so that a mitochondrial 
disorder, which causes a decrease in the production of ATP, represents a clear threat to the 
viability of the neurons and glial cells, the functionality of neural networks, and 
consequently the normal functions of the brain can be changed. The alteration in the 
regulation of calcium levels by the failures of the mitochondrial buffer and the release of 
mitochondria-bound calcium contributes to a severe injury of brain tissue in response to 
excitotoxicity by glutamate, oxidative stress, or metabolic damage such as trauma. Similarly, 
an abnormal increase in the generation of ROS by the mitochondria also puts at risk cell 
viability because many shock-mechanism absorbers might be overwhelmed (Kann & 
Kovács, 2007).The result is an oxidative damage to the structural and regulatory proteins of 
the cell membranes that modulate the redox state, and can lead to abnormal activity in 
various ionic channels. Another event that puts cell viability at risk is the formation of the 
mitochondrial permeability-transition pore (mPTP), which occurs in response to a 
mitochondrial overload of calcium in the presence of high levels of ROS. The mitochondrial 
permeability-transition pore is characterized by an increase in nonspecific permeability in 
the inner mitochondrial membrane, loss of membrane potential, a possible rupture of the 
outer membrane, and a severe mitochondrial swelling. When the opening of the mPTP is 
transitory, the release of cytochrome C from the intermembranal space can activate the 
caspase cascade that leads to apoptosis. If the opening of the mPTP is prolonged, the 
mitochondrial content is reduced by quickly causing necrosis (Kann & Kovács, 2007). 
 
 
Fig. 7. Electronic microphotography that shows the effects of an oxidative stress state caused 
by ozone exposure on the neuron mitochondria of the rat hippocampus (30.000x). Observe 
the loss of the external mitochondrial membrane and damage of the mitochondrial crests 
after exposure to ozone (right) 
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9. Oxidative stress state and neurodegenerative process in an animal model 
9.1 Ozone as a model for oxidative stress 
Various methods have been used to deal with the study of oxidative stress and its biological 
significance in the organism. This ranges from biochemistry, cell culture, and animal models 
to clinical studies. Ozone exposure causes the generation of ROS (Chen & Qu, 1997; 
Kennedy et al., 1992; Pryor, 1994; Pryor & Church, 1991; Romieu et al., 1998, Saintot et al., 
1999) and the formation of relatively stable products (Bocci, 2006; Pryor et al.,1995) able to 
oxidize DNA, proteins (Kanofsky & Sima, 1993), and lipid membranes (Postlethwait et al., 
1998), which if they are not offset causes damage and cell death. In the epithelial lining of 
the lung, the fluid is characterized by high concentrations of antioxidants, mainly ascorbic 
acid and glutathione (GSH) (Bocci, 2006). To react with these antioxidants a portion of the 
inhaled ozone is destroyed. The pulmonary antioxidant defenses are able to neutralize the 
damage, depending on the dose and exposure time, but when they are overwhelmed a chain 
of chemical reactions begins that leads to the formation of ROS, caused by secondary 
exposure to ozone. The ROS pass into the blood, and through the bloodstream reach all the 
organism, producing a state of widespread oxidative stress (Rivas-Arancibia et al., 2000, 
2003). The mechanism of toxicity of ozone is explained as a cascade of reactions (Pryor et al., 
1995) in which inhaled ozone reacts with molecules in the fluid of the epithelial lining 
producing ROS and toxic byproducts, which in turn are able to cause other reactions in the 
blood. This cascade of reactions is responsible for the toxic effects of ozone both in the lung 
microenvironment and throughout the body (Ballinger et al., 2005; Bocci, 2006; Pryor et al., 
1995). Although the majority of the studies on the effects of oxides of carbon, sulphur, 
nitrogen, and ozone were made in animals, they indicate that damage may be caused in 
humans when air pollution increases. Oxidative stress caused by acute or prolonged 
exposure to ozone causes alterations in the brain plasticity that are manifested by the deficit 
in the learning processes, memory, and motor activity behavior (Rivas-Arancibia et al., 2000; 
Dorado-Martínez et al., 2001). Exposure to low doses of ozone over a long time causes a 
process of progressive neurodegeneration (Angoa-Pérez et al., 2006; Pereyra-Muñoz et al., 
2006, Rivas-Arancibia 2010). 
Brain tissue is most vulnerable to oxidative damage caused by its high consumption of 
oxygen, a high metabolic rate, and low levels of antioxidant enzymes, such as SOD, 
glutathione peroxidase, and catalase. A large increase of lipid peroxidate levels is caused by 
an increase in ROS, because of the brain’s high content of polyunsaturated fatty acids that 
are highly susceptible to oxidation. Different brain structures show differences in their 
response to oxidative damage (Hermida-Ameijeiras et al., 2004). 
There is clear evidence that air pollution causes an oxidizing environment for humans. High 
levels of contamination in highly populated cities are correlated with the rise of a number of 
pathologies, such as autoimmune, degenerative, and neurodegenerative diseases. When 
using a model of oxidative stress, produced by ozone exposure to low doses (0.25 ppm) for 4 
hours daily for different times (7, 15, 30, 60, and 90 days), healthy animals developed a 
process of progressive neurodegeneration that depends on the exposure time (Angoa-Perez 
et al., 2006; Pereyra-Muñoz et al., 2006; Rivas-Arancibia et al., 2010, Santiago-Lopez et al., 
2010).  
The increase in the levels of oxidized lipids, proteins, carbohydrates, and nucleic acids are 
used as indicators of the state of oxidative stress. Levels of antioxidant enzymes and their 
activity are used as indicators of antioxidant capacity. The determination of oxidized 
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biomolecules and the activity of antioxidant systems clearly determine the redox state in 
which an individual is found, e.g. we can find high levels of oxidized lipids or proteins, but 
these can be accompanied by an increase in the activity of the SOD and glutathione 
peroxidase, or an increase in the levels of reduced glutathione. This indicates that oxidative 
stress is compensated for because the increase of the prooxidants is accompanied by an 
increase in the antioxidant systems, which leads to a balanced redox system and tissue 
changes that are reversible. If the oxidation of the biomolecules increases and there is a 
decrease in the activity of antioxidant systems, we can then infer that there is a loss of redox 
balance that produces a state of oxidative stress. This is important to define because many 
experimental models do not consider these effects and the results are often contradictory. As 
an example of the models that used ozone, the administration of high doses of this gas in 
animals may cause a strong antioxidant response and then the increase in the levels of 
antioxidants has a repair effect on the organism. However, in Wistar rats more than 2-years 
old, this response causes a severe neuronal and endothelial damage because older animals 
have a decreased antioxidant activity level in a chronic oxidatively stressed state, and this 
also occurs in chronic-degenerative diseases. 
Another important factor is the dose and exposure time. In healthy young animals exposed 
to low doses of ozone for 4-h daily for a prolonged time, a chronic oxidative stress state is 
generated that causes a process of progressive neurodegeneration. This degenerative 
process becomes irreversible after 30 days of exposure to this gas. Though animals are no 
longer exposed to ozone the damage continues to make progress. The progressive 
neurodegeneration process is shown in figures 8,9,10 in which oxidative stress, depending 
on the time of exposure to ozone, increases the immunoreactivity to p53 and the 
translocation of p53 to the nucleus, indicating an increase in cell death by apoptosis.  
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Fig. 8. The effect of oxidative stress on P53 immunoreactivity caused by chronic exposure to 
low ozone doses for different times (15, 30, and 60 days) in different brain structures 
(striatum, hippocampus, and substatia nigra). Note immunoreactivity increases in the 
nucleus as a function of the time of exposure to ozone 
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This result shows that oxidative stress by itself is able to produce damage and neuronal 
death, which is accompanied by the loss of regulation of the inflammatory response and by 
changes in astrocytes and microglia.  
We can therefore conclude that oxidative stress caused by ozone produces a state of 
progressive neurodegeneration, which is characterized by neuronal death, changes in the 
microglia, loss of regulation of the inflammatory response, and loss of the ability of brain to 
be repaired. 
 
 
Fig. 9. Double micrograph that shows the effects of oxidative stress on astrocytes (green) 
and microglia (red) in the rat hippocampus exposed chronically to low ozone doses. Control 
(A) 30 days (B) 60 days (C), and 90 days (D) of ozone exposure (40x). Note that oxidative 
stress causes morphological changes in astrocytes and phenotypic changes in microglia 
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Fig. 10. Micrograph that shows the effects of oxidative stress on the hippocampal neurons of 
the rat exposed to ozone for 30 days. Control (A) and 30 days of ozone exposure (B) (100x) 
www.intechopen.com
 Oxidative Stress and Neurodegenerative Disease 
 
75 
10. Neurodegenerative diseases 
Neurodegenerative diseases (diseases in which nerve cells degenerate and die) have a 
variety of symptoms, can affect different parts of the brain, and the causes are multifactorial 
and still are not entirely clear. All of them have in common the altered mitochondrial 
function, increased oxidative damage, presence of abnormal aggregates of proteins and 
proteasomes, alteration in the metabolism of iron, and changes and dysregulation of 
inflammation and exitotoxicity. All these form a vicious cycle and can initiate cell death and 
quickly recruit other cells in its destructive purpose. Oxidized proteins are usually removed 
by the proteasomes. Inhibition of the proteasomes by a redox state alteration leads to an 
accumulation of abnormal proteins and ROS production. The ROS-producing agents can 
initiate neurodegeneration because the ROS causes damaged mitochondria, producing an 
increase in the Ca2+, and inhibiting the function of the proteasomes. The iron in several areas 
of the brain increases with age and with other metals promotes oxidation, and with this the 
aggregation of various proteins. 
10.1 Oxidative stress and Alzheimer’s disease 
Alzheimer's disease is characterized by the pathogenic presence of intracellular tangles of 
tau protein containing hyperphosphorylated and extracellular senile plaques formed 
primarily by ǃ-amyloid oligomers. Different scenarios have been proposed that explain the 
causes involved in the development of the disease; one is oxidative stress. There are several 
studies suggesting that accumulation of free radicals in excess formed during normal 
metabolism is able to cause oxidation of proteins, DNA and RNA, lipid peroxidation, and 
modification of sugars, thus generating massive neuronal death in the hippocampus, 
associated with parts of the neocortex (Praticò, 2008). The formation of senile plaques is 
caused by the intracellular and extracellular accumulation of insoluble beta amyloid in the 
brain. The peptide beta amyloid is generated by the splitting of the amyloid precursor 
protein (APP) that involves the enzymes alpha, beta, and gamma secretases (Rajendran, 
2008). There are multiple forms of oligomerization that can be found in the beta amyloid 
peptide. This peptide can play various physiological and pathological roles depending on  
 
 
Fig. 12. Microphotography that shows the effects of a chronic, oxidative-stress state on the 
expression of the insoluble form of ǃ-amyloid 1-42 immunoreactivity in a healthy rat 
exposed to low ozone doses for 4 h daily for 90 days 
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the path of its formation. The beta amyloid may deposit in specific regions of brain as 
amyloid plates that form. Break up of the APP is in two phases; a nonamyloidogenic 
pathway and an amyloidogenic pathway (Rajendran, 2008). In the nonamyloidogenic 
pathway, the alpha secretase cleaves in the position of the amino acid 83 from the side 
carboxyl terminal producing a long ectodominion amino (N) - terminal (sAPPα). The result 
of this process is the formation of C83, which is retained by the membrane to be cut by the 
gamma secretase forming short fragments of p3. The breakdown by the alpha secretase 
occurs in the region of beta amyloid.  
The amyloidogenic pathway is an alternate way of rupturing of the APP that leads to the 
generation of beta amyloid. This path is caused by the beta secretase that cuts in the amino 
acid 99 allowing the release of sAPPǃ in the extracellular space. Subsequently the rupture of 
this fragment between residue 38 and 43 by Ǆ-secretase releases an intact peptide Aǃ. The 
full length of the ǃ-amyloid peptide is 40 residues (Aǃ40), with 10% a variant of 42 residues 
(Aǃ42). This latter variant is more hydrophobic and easily causes formation of fibrils and is 
the form of this peptide which predominates in beta amyloid plaques (Rajendran, 2008; 
Tillement et al., 2010). 
Lower levels of the intracellular ǃ-amyloid peptide produce the internalization of the 
amyloid precursor protein. This internalization is mediated by a low density receptor-
related lipoprotein 1B (LRP1B), one of the members of the LDL family, This receptor 
typically joins the precursor protein of amyloid in the plasma membrane to prevent the 
internalization of the beta amyloid peptide by reducing its production. The failure of these 
mechanisms and the association of the tau protein causes the internalization of extracellular 
protein neurons, which gives rise to the production and outsourcing of the insoluble beta 
amyloid isoform. 
Synthesis of soluble ǃ-amyloid is altered during this phase and increases the synthesis of the 
insoluble, unfolded ǃ-amyloid as part of the insoluble plates of the ǃ-amyloid. The loss of 
redox homeostasis, both endogenous or exogenous, produces a state of chronic oxidative 
stress that increases the production of ROS and RNS, causes a reduced expression or activity 
of antioxidant systems, accelerates ageing, and plays a key role in the pathogenesis and the 
course of Alzheimer's disease by the altering of many signaling metabolic pathways in the 
cell by promoting mutations or altering the postransductional mechanisms. The chronic 
disruption of the oxidation-reduction balance, causes bad protein folding, products of 
advanced glycosylation, overload of peroxidation of saturated fatty acids (hydroxynonenal, 
HNE) (Liu, 2008), oxidation of cholesterol, disturbances in the insulin receptor to cause 
insulin resistance, and oxidation of LDL receptors involved in the reentry of peptide or the 
APP (Liu, 2008). We can infer that Alzheimer's is the final manifestation of a series of 
oxidative alterations of metabolism, which involve different biomolecules, in which the loss 
of the oxide-reduction balance plays a decisive role in the formation of the phosphorylated 
tau protein and insoluble beta amyloid . 
10.2 Environmental toxics and Parkinson’s disease 
The initiation and development of the Parkinson disease’s (PD) is still uncertain. The 
pathophysiology is complex and multifactorial and often differs among affected individuals. 
A large number of studies have provided evidence that loss of redox regulation contributes 
to all forms of PD, but it has not yet been determined whether the ROS are a primary event 
or a consequence of the pathogenic factors. An overproduction of ROS is unquestionably an 
important mediator in cell death in PD (Berg, 2004). It has been suggested that the PD  
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pathogenesis may involve two processes; damage from a specific disease or that combined 
with damage associated with normal aging. The PD is the result of neurodegeneration in 
specific areas of the brain (substantia nigra, pars compact, and putamen) resulting in a 
decrease of dopamine (Cui, 2004). Factors involving dopamine, neuromelanin, increase in 
the deposits of iron in the substantia nigra, a decrease of ferritin and glutathione (GSH), a 
deficiency in the role of the complex I mitochondrial respiratory chain, mitochondrial 
dysfunction and excitotoxicity may be the cause or result of the ROS. Toxins such as 
paraquat, MPTP, and rotenone have proven to increase the risk of PD in humans. Studies 
with animal models and cells reveal the oxidative and inflammatory properties of these 
toxins, and their ability to activate glial cells that subsequently destroy the neighboring 
dopaminergic neurons. The activity of the complex I mitochondria is deficient in the 
substance nigra (SN) in PD and can be associated with a genetic abnormality or be the result 
of oxidative stress. The postulate of a defect in the mitochondrial DNA is still uncertain. It 
has been shown in the culture of dopaminergic cells that the decrease of glutathione, from 
the selective loss in the activity of the mitochondrial complex I is an important feature of PD. 
10.2.1 Dopaminergic system  
Dopamine (DA) is a catecholamine that plays an important role in the human brain as an 
inhibitory neurotransmitter, particularly involved in the regulation of motor function. It is 
synthesized in the nerve terminals from tyrosine, the precursor of the amino acid 
dopaminergic neurons. The synthesis begins with the formation of L-DOPA, through the 
action of tyrosine hydroxylase and the biopteridines. The former enzyme is the limiting 
enzyme in the synthesis of dopamine. The activity is strictly controlled. L-DOPA is 
metabolized to form DA by an aromatic amino acid decarboxylase. In the nerve terminals, 
the DA is stored in synaptic vesicles with an acid content because it prevents the 
autoxidation of the DA until it is released. The action ends with the uptake of DA by a 
membrane transporter and the subsequent reuse or catabolism by the enzyme monoamino-
oxidase (MAO) or the catechol-o-methyltransferase (COMT). Within the brain, 
dopaminergic systems are involved in processes of motivation, learning, memory, and 
motor control. It is estimated that dopamine is > 80% of the total content of catecholamines 
in the brain. The greatest risk of the DA is that this catechol group oxidizes easily through a 
process that involves the transfer of an electron to oxygen. Thus, this oxidation results in the 
formation of an superoxide anion, hydrogen peroxide, hydroxyl radical, and other ROS that 
are able to generate a state of oxidative stress and start a process of neurodegeneration.  
10.2.2 Dopamine as a source of ROS in the CNS 
Mechanisms through which the DA stimulates the production of ROS have been proposed. 
These depend on the presence or absence of enzyme mediators. It is known that the DA of 
the SN and the striatum (STR) is deaminated by the enzyme MAO located in the outer 
membrane of the mitochondrion. This reaction has resulted in the production of a 
superoxide radical, hydroxyl radical, and hydrogen peroxide (Graham, 1978). Proposed 
mechanisms through which the DA stimulates the production of ROS depend on the 
presence or absence of enzyme mediators.  
The endogenous dopamine-derived N-methyl(R)salsolinol is one of the most studied 
derivatives of DA for two reasons. It is present in the human brain and can easily become a 
neurotoxin able to cause cell death. It has been proposed that this compound can be formed 
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by an enzymatic pathway that involves a synthase or a nonenzymatic pathway by the 
condensation of the DA with acetaldehyde (Naoi et al., 1996).Another derivative of the DA 
is the tetrahydropapaveroline (THP), which is obtained from enzymatic catabolism. The 
THP by itself is able to cause necrosis in neuroblastom cells and is related to the pathogenesis 
of Parkinson's disease. Derivatives of the metabolism of DA act as proneurotoxins in the 
development of Parkinson's disease. It is known that certain components of tobacco smoke 
may react with these proneurotoxins preventing its activation. This may explain the 
beneficial effect of smoking on the incidence of Parkinson's disease (Hermida-Ameijeiras et 
al., 2004). 
10.2.3 The autoxidation of dopamine 
Another mechanism through which DA can contribute to the formation of ROS is its 
spontaneous autoxidation. The DA is a molecule of the catechol group that can easily 
oxidize nonenzymatically to form a series of electrochemical type quinoide species. The 
initial step in the oxidation of the DA involves a reaction with molecular oxygen to form two 
molecules of the superoxide anion and DA-o-quinone. The formation of the superoxide 
anions during the autoxidation of the DA leads to the production of hydrogen peroxide by 
the dismutation of superoxide. The DA-o-quinone then undergoes an intramolecular 
clyclization to form 5,6-dihydroxiquinoline, which is subsequently oxidized by the  
DA-o-quinone to form dopaminochrome. This compound undergoes a rearrangement to 
form 5,6-dihydroxyindole, which in turn is oxidized to an indole quinone. The next  
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Fig. 13. Showing the effect of oxidative stress on the pathological process and the pathway 
that is followed depending on the regulation or nonregulation of the inflammatory 
responses 
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polymerization process eventually leads to the generation of a dark pigment called 
neuromelanin. The dark appearance of the SN is caused by the presence of this pigment 
containing products derived from the oxidation of the cysteinyl-DA. When the autoxidation 
of the DA takes place in the presence of L-cysteine, the DA-o-Quinone undergoes a 
nucleophilic attack by the thiol of the amino acid group to form cysteinyl-DA. This differs 
from normal oxidation of the DA to form neuromelanin (Hermida-Ameijeiras et al., 2004). 
11. Conclusions 
In a balanced oxidation-reduction system, reactive species have an effect as signaling or a 
regulator of both the glia and neurons in internal signaling pathways, act as regulators of 
the immune response, which includes inflammatory response, and as regulators of the cell 
cycle, neuroplasticity, and metabolism. The short-term loss of the oxidation-reduction 
balance causes an increase in the activity of antioxidant systems to counteract the oxidative 
stimulus. The endogenous increase of the antioxidant systems play a restorative role of the 
organism. An enlightening physiological example of this is the repairing role of exercise in 
chronic degenerative diseases, which is explained by a rise in free radicals as a consequence 
of an increase in endogenous antioxidant systems.  
The loss of the redox balance (as shown in the model of oxidative stress caused by ozone) 
implies a loss of regulation of the inflammatory response, which then causes a reparative 
and self-limiting response. This becomes a perpetual response, a vicious cycle, in which 
there is mitochondrial failure that leads to a lack of ATP, an increase in the state of oxidative 
stress, loss of regulation of inflammatory markers, blocking of antioxidant systems, inability 
to synthesize new proteins, disorders of the proteasome, accumulation of misfolded 
proteins, and the conformational change in key receptors involved in metabolism and cell 
signaling. All of them, established slowly over time, can produce chronic degenerative 
diseases and neurodegenerative diseases as a manifestation of a series of alterations caused 
by multiple factors, including that of the establishment of a state of chronic-oxidative stress. 
This plays a key role in the loss of the regulation of cell signaling, of the different responses 
that lead to neuronal death and loss of brain repair and the altering of the process of 
neurogenesis. All these are clinically manifested into neurodegenerative diseases long after 
the vicious cycle has started. The discovery of early oxidative markers specific to each 
neurodegenerative disease can allow an early diagnosis and break the vicious cycle 
established by oxidative stress. This can be seen occurring in the near future for the 
treatment and detection of these diseases.  
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